Generate interest, access liquidity without selling, and execute trades seamlessly. All in one platform.
Geographic restrictions, eligibility, and terms apply.
Get started with Nexo.
Earn up to 15% annual interest with Nexo.
Access competitive interest rates on your digital assets.
Generate interest, borrow against your crypto, and trade a range of cryptocurrencies — all in one platform.
Geographic restrictions, eligibility, and terms apply.
software for email automation (newsletters, transaction mails, etc.)
This is an archive for old versions of OpenEMM. You will find the latest version of OpenEMM here: https://wiki.openemm.org
OpenEMM is a browser-based enterprise application for email automation like info and marketing newsletters, transaction mails or multi-stage email campaigns.
OpenEMM offers tons of features for professional users, among them: a great user interface, template-based HTML mailings, automatic bounce management, mail opening and link tracking, lots of graphical realtime...
Proyecto java el cual recibe CFD 2.0, 2.2 /CFDi 3.0, 3.2 ValidadorCFD a través de WebService para realizar las validaciones necesarias del SAT como son :sello, folio, serie, no. certificado,esquema, etc.Hecho para integrar a través de spring integration servicios de negocio.
This HTML editor is a just a simple program, but with powerful features. Based off of NetBeans and it's UI, I hope to allow the same customization interface and easy-to-use program feeling as many OpenSource programs. With support for CSS, HTML1-5, and XML it is very useful and plans are made to include server-side support and well as a testing enviornment.
VNC for use with the BrowserMob Selenium JavaScript Validator. This tool is made available for users of BrowserMob FREE Website Monitoring and Load Testing. The BrowserMob Local Validation Service can be downloaded from https://browsermob.com/tools.
Avenzoar is a one-year exploration of renal cell carcinoma morphology and its related single nucleotide polymorphisms (SNPa) as a method of automating diagnosis of cancer by using a computer-aided decision tree controlled by analytical statistics.